Conclusion
The COVID-19 pandemic continues to present innumerable unique challenges
throughout the healthcare system. Otolaryngology is an especially
challenging subspecialty at this time, with the intrinsic exposure risks
to providers of procedures that generate aerosols. Practice is even more
complicated when patients present with complex cancers and coincident
immunosuppression. Clinical decision-making requires careful weighing of
the competing risks of various approaches, and honest communication with
the patient. A comprehensive, multidisciplinary approach, including the
addition of specialties such as Infectious Disease, is the preferred
approach to managing these patients in these unusual circumstances.